Natus Medical traded at $32.96 this Wednesday July 20th, increasing $0.03 or 0.09 percent since the previous trading session. Looking back, over the last four weeks, Natus Medical gained 2.07 percent. Over the last 12 months, its price rose by 32.58 percent. Looking ahead, we forecast Natus Medical to be priced at 32.05 by the end of this quarter and at 29.46 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abiomed 281.71 -12.06 -4.11% -15.33%
AngioDynamics 23.45 -0.25 -1.05% -13.05%
Accuray 2.07 -0.07 -3.27% -48.64%
AtriCure 48.92 -2.52 -4.90% -33.08%
Boston Scientific 41.03 0.06 0.15% -3.80%
Cooper Companies 325.63 -8.04 -2.41% -19.90%
Artivion Inc 21.32 -0.63 -2.87% -20.24%
Cardiovascular Systems 15.71 -1.00 -5.98% -56.94%
Edwards Lifesciences 101.44 -4.02 -3.81% -9.39%
General Electric 74.93 -0.25 -0.33% -29.36%
Globus Medical 63.79 0.27 0.43% -16.65%
Integra LifeSciences 54.97 -0.63 -1.13% -20.85%
Inogen 27.61 0 0% -57.25%
Masimo 148.17 -6.44 -4.17% -44.32%
Medtronic 93.10 -0.48 -0.51% -25.70%
Mesa Laboratories 191.27 -10.31 -5.11% -31.94%
Orthofix International 21.98 -1.08 -4.68% -44.11%
Koninklijke Philips 20.05 -0.68 -3.28% -55.11%
Philips 19.70 -0.61 -3.02% -48.19%
PerkinElmer 151.49 -2.60 -1.69% -17.44%
Insulet 258.68 -4.38 -1.67% -7.42%
Surmodics 35.35 -1.34 -3.65% -34.80%
Thermo Fisher Scientific 580.87 -3.08 -0.53% 8.12%
Tandem Diabetes Care 53.84 -6.26 -10.42% -48.07%
Trinity Biotech 1.40 0.04 2.94% -41.18%

Indexes Price Day Year
USND 12494 -150.53 -1.19% -15.51%
US2000 1913 -28.31 -1.46% -14.58%

Natus Medical
Natus Medical Incorporated provides healthcare solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. The Company provides product solutions for three end markets: Neuro, Newborn Care and Hearing & Balance. Its Neuro includes products and services that provide diagnostic, therapeutic and surgical solutions in neurodiagnostics, neurocritical care and neurosurgery. Its Newborn Care includes products and services for newborn care, including hearing screening, brain monitoring, eye imaging, jaundice management and various disposable newborn care supplies. Its Hearing portfolio includes products for hearing assessment and diagnostics and hearing aid fitting, including computer-based audiological, otoneurologic and vestibular instrumentation for hearing care professionals. Its Balance portfolio provides diagnosis and assessment of vestibular and balance disorders.